Michael Barbella, Managing Editor01.08.24
New year, new leadership at Orthofix Medical Inc.
With the dawn of 2024, Massimo Calafiore has officially assumed his role as president, CEO, and board member. In conjunction with the start of Calafiore's tenure, the company has appointed Julie Andrews as chief financial officer (CFO). Andrews previously served as CFO for Smart Wires Technology, where she led all finance, tax, treasury, accounting, information technology, and investor relations functions. Prior to that role, Andrews was senior vice president, Global Finance, for Wright Medical Group, a global medical device company focused on extremities and biologics that was acquired by Stryker Corp. in 2020, and before that, she was vice president of Finance for the Spine and Biologics division of Medtronic Inc.
“I am thrilled to announce that Massimo has officially started in his role as [resident and CEO and am equally excited to welcome Julie to Orthofix as incoming CFO,” Orthofix Board Chair and former Interim CEO Catherine Burzik said. “Our search for these critical management roles was executed quickly and thoroughly, with many qualified candidates expressing interest in leading Orthofix. We are confident we have chosen two visionary executives who will bring meaningful perspectives and expertise to the company and that their leadership will serve us well in the years ahead.”
Calafiore joined LimaCorporate S.p.A., a global orthopedics company in September 2022, where he served as CEO until the Jan. 3, 2024, acquisition of LimaCorporate by Enovis Corporation. Prior to this he served as executive vice president and chief commercial officer of NuVasive Inc. During his tenure at NuVasive, Calafiore was president of NuVasive Specialized Orthopedics (formerly Ellipse Technologies). Earlier in his career, Calafiore worked for Waldemar Link GmbH & Co. KG and served in various leadership roles across multiple business segments, including orthopedics, lower extremities, and spine.
Calafiore earned his M.Sc. in mechanical engineering from the University of Catania and an MBA from New York University.
“I am honored to officially begin this role at this important time for the company, and I am excited to welcome Julie to the team next week," Calafiore stated. "I look forward to working with the more than 1,600 employees who dedicate themselves to furthering our mission to deliver meaningful and life-improving technologies for our surgeon customers and their patients.”
Andrews joined Smart Wires Technology, a global transmission grid technology company focused on enabling the transition to renewable energy, as CFO in 2021. From 2012 to 2020, she was senior vice president, Global Finance and vice president, Global FP&A, and chief accounting officer at Wright Medical Group, where she led a 170-person finance team. Prior to this, Andrews spent many years in roles of increasing responsibility at Medtronic Inc., including as vice president of Finance for the Spine and Biologics division, where she provided oversight of all FP&A and accounting functions. Early in her career, Andrews worked as a senior financial analyst for Thomas & Betts and as an auditor for Thomas Havey LLC.
Currently, Andrews serves on RxSight Inc.'s board. She earned a bachelor of science degree in accounting from Indiana University. She also participated in advanced leader and director development programs at both Medtronic and Wharton School of Business.
Orthofix is a global spine and orthopedics company offering biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and a surgical navigation system. Its products are distributed in approximately 68 countries worldwide. The Company is headquartered in Lewisville, Texas, and has primary offices in Carlsbad, Calif., with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, Calif.; Toronto, Canada; Sunnyvale, Calif.; Wayne, Pa.; Olive Branch, Miss.; Maidenhead, U.K.; Munich, Germany; Paris; and Sao Paulo, Brazil.
With the dawn of 2024, Massimo Calafiore has officially assumed his role as president, CEO, and board member. In conjunction with the start of Calafiore's tenure, the company has appointed Julie Andrews as chief financial officer (CFO). Andrews previously served as CFO for Smart Wires Technology, where she led all finance, tax, treasury, accounting, information technology, and investor relations functions. Prior to that role, Andrews was senior vice president, Global Finance, for Wright Medical Group, a global medical device company focused on extremities and biologics that was acquired by Stryker Corp. in 2020, and before that, she was vice president of Finance for the Spine and Biologics division of Medtronic Inc.
“I am thrilled to announce that Massimo has officially started in his role as [resident and CEO and am equally excited to welcome Julie to Orthofix as incoming CFO,” Orthofix Board Chair and former Interim CEO Catherine Burzik said. “Our search for these critical management roles was executed quickly and thoroughly, with many qualified candidates expressing interest in leading Orthofix. We are confident we have chosen two visionary executives who will bring meaningful perspectives and expertise to the company and that their leadership will serve us well in the years ahead.”
Calafiore joined LimaCorporate S.p.A., a global orthopedics company in September 2022, where he served as CEO until the Jan. 3, 2024, acquisition of LimaCorporate by Enovis Corporation. Prior to this he served as executive vice president and chief commercial officer of NuVasive Inc. During his tenure at NuVasive, Calafiore was president of NuVasive Specialized Orthopedics (formerly Ellipse Technologies). Earlier in his career, Calafiore worked for Waldemar Link GmbH & Co. KG and served in various leadership roles across multiple business segments, including orthopedics, lower extremities, and spine.
Calafiore earned his M.Sc. in mechanical engineering from the University of Catania and an MBA from New York University.
“I am honored to officially begin this role at this important time for the company, and I am excited to welcome Julie to the team next week," Calafiore stated. "I look forward to working with the more than 1,600 employees who dedicate themselves to furthering our mission to deliver meaningful and life-improving technologies for our surgeon customers and their patients.”
Andrews joined Smart Wires Technology, a global transmission grid technology company focused on enabling the transition to renewable energy, as CFO in 2021. From 2012 to 2020, she was senior vice president, Global Finance and vice president, Global FP&A, and chief accounting officer at Wright Medical Group, where she led a 170-person finance team. Prior to this, Andrews spent many years in roles of increasing responsibility at Medtronic Inc., including as vice president of Finance for the Spine and Biologics division, where she provided oversight of all FP&A and accounting functions. Early in her career, Andrews worked as a senior financial analyst for Thomas & Betts and as an auditor for Thomas Havey LLC.
Currently, Andrews serves on RxSight Inc.'s board. She earned a bachelor of science degree in accounting from Indiana University. She also participated in advanced leader and director development programs at both Medtronic and Wharton School of Business.
Orthofix is a global spine and orthopedics company offering biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and a surgical navigation system. Its products are distributed in approximately 68 countries worldwide. The Company is headquartered in Lewisville, Texas, and has primary offices in Carlsbad, Calif., with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, Calif.; Toronto, Canada; Sunnyvale, Calif.; Wayne, Pa.; Olive Branch, Miss.; Maidenhead, U.K.; Munich, Germany; Paris; and Sao Paulo, Brazil.